| The toxicology of heparin reversal with protamine: past, present and future E Sokolowska, B Kalaska, J Miklosz, A Mogielnicki Expert opinion on drug metabolism & toxicology 12 (8), 897-909, 2016 | 120 | 2016 |
| Heparin-binding copolymer reverses effects of unfractionated heparin, enoxaparin, and fondaparinux in rats and mice B Kalaska, K Kaminski, J Miklosz, S Yusa, E Sokolowska, A Blazejczyk, ... Translational Research 177, 98-112. e10, 2016 | 28 | 2016 |
| Pharmacogenetic considerations of anticoagulant medication J Miklosz, B Kalaska, A Mogielnicki J Physiol Pharmacol 69 (4), 2018 | 17 | 2018 |
| Anticoagulant properties of poly (sodium 2-(acrylamido)-2-methylpropanesulfonate)-based di-and triblock polymers B Kalaska, K Kaminski, J Miklosz, K Nakai, SI Yusa, D Pawlak, ... Biomacromolecules 19 (7), 3104-3118, 2018 | 17 | 2018 |
| The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target B Kalaska, J Miklosz, K Kamiński, B Musielak, SI Yusa, D Pawlak, ... RSC advances 9 (6), 3020-3029, 2019 | 12 | 2019 |
| Heparin-binding copolymer as a complete antidote for low-molecular-weight heparins in rats B Kalaska, J Miklosz, K Kamiński, J Swieton, A Jakimczuk, SI Yusa, ... Journal of Pharmacology and Experimental Therapeutics 373 (1), 51-61, 2020 | 10 | 2020 |
| The inhibitory effect of protamine on platelets is attenuated by heparin without inducing thrombocytopenia in rodents J Miklosz, B Kalaska, K Kaminski, M Rusak, K Szczubialka, ... Marine drugs 17 (9), 539, 2019 | 7 | 2019 |
| The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review A Frackiewicz, B Kalaska, J Miklosz, A Mogielnicki Thrombosis Journal 21 (1), 58, 2023 | 6 | 2023 |
| Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer JM Hermanowicz, B Kalaska, K Pawlak, B Sieklucka, J Miklosz, ... Pharmaceutics 13 (8), 1222, 2021 | 6 | 2021 |
| Cardiovascular and respiratory toxicity of protamine sulfate in zebrafish and rodent models J Miklosz, B Kalaska, P Podlasz, M Chmielewska-Krzesińska, ... Pharmaceutics 13 (3), 359, 2021 | 6 | 2021 |
| Monitoring of anticoagulant activity of Dabigatran and Rivaroxaban in the Presence of Heparins A Jakimczuk, B Kalaska, K Kamiński, J Miklosz, SI Yusa, D Pawlak, ... Journal of Clinical Medicine 11 (8), 2236, 2022 | 4 | 2022 |
| Anionic and cationic block copolymers as promising modulators of blood coagulation J Swieton, K Kaminski, J Miklosz, A Mogielnicki, B Kalaska European Polymer Journal, 112452, 2023 | 2 | 2023 |
| Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study J Nowowiejska, A Baran, JM Hermanowicz, J Mikłosz, KA Kamiński, ... Metabolites 12 (9), 877, 2022 | 2 | 2022 |
| The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats B Kalaska, J Miklosz, J Swieton, A Jakimczuk, D Pawlak, A Mogielnicki Vaccine 40 (13), 1996-2002, 2022 | 2 | 2022 |
| Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice J Swieton, J Miklosz, SI Yusa, K Szczubialka, D Pawlak, A Mogielnicki, ... International Journal of Molecular Sciences 22 (20), 11149, 2021 | 1 | 2021 |
| P372 Heparin binding copolymer reverses the anticoagulant activity of low molecular weight heparins: safety and efficacy data in rats J Miklosz, B Kalaska, K Kaminski, K Szczubialka, D Pawlak, ... Cardiovascular Research 114 (suppl_1), S95-S95, 2018 | 1 | 2018 |
| Novel synthetic copolymers able to bind unfractionated and low molecular weight heparins B Kalaska, K Kaminski, E Sokolowska, J Miklosz, S Yusa, K Szczubialka, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 13, 371-371, 2015 | 1 | 2015 |
| PB1404 Comparison of Cardiovascular and Respiratory Toxicity of Heparin Antidotes: Protamine Sulfate, PER977 and Heparin-Binding Copolymer (HBC) J Miklosz, J Swieton, B Kalaska, S Yusa, K Szczubialka, D Pawlak, ... Research and Practice in Thrombosis and Haemostasis 7, 101680, 2023 | | 2023 |
| The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative A Frackiewicz, B Kalaska, J Miklosz, A Mogielnicki BioMed Central 21, 14, 2023 | | 2023 |
| Monitoring of Cardiorespiratory Parameters in Rats—Validation Based on Pharmacological Stimulation J Miklosz, B Kalaska, S Zajaczkowski, D Pawlak, A Mogielnicki Pharmaceuticals 14 (12), 1223, 2021 | | 2021 |
